CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: December 15, 2006
Result type: Reports
Project Number: S0090
Product Line: Common Drug Review

Generic Name: Lumiracoxib

Brand Name: Prexige

Manufacturer: Novartis Pharmaceuticals Canada Inc.

Indications: Osteoarthritis (Knee)

Submission Type: New

Project Status: Complete

Date Recommendation Issued: July 25, 2007

Recommendation Type: Do not list